David Grayzel
Impact in
- Psychiatry and Mental health top 5%
- Migraine and Headache Studies
-
- Trigeminal Neuralgia and Treatments
Papers in
-
- Heat shock proteins research 9
- Oncology 6
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Steven Sweeney (3 shared papers)Peter J. Goadsby (2 shared papers)Egilius L.H. Spierings (2 shared papers)David W. Dodick (1 shared paper)John R. Walker (5 shared papers)Lecia V. Sequist (4 shared papers)Pasi A. Jänne (3 shared papers)Scott Gettinger (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Blood (6 papers)Frontiers in Pharmacology (1 paper)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
David Grayzel
23 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 68
- Psychiatry and Mental health 370
- Pathology and Forensic Medicine 197
- Gastroenterology 57
- Hematology 98
- Pulmonary and Respiratory Medicine 215
Countries citing papers authored by David Grayzel
This map shows the geographic impact of David Grayzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Grayzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Grayzel more than expected).
Fields of papers citing papers by David Grayzel
This network shows the impact of papers produced by David Grayzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Grayzel. The network helps show where David Grayzel may publish in the future.
Co-authors
The 25 scholars most cited alongside David Grayzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 304 | |
| 2 | 2010 | 280 | |
| 3 | 2007 | 123 | |
| 4 | 2013 | 70 | |
| 5 | 2017 | 57 | |
| 6 | 2015 | 48 | |
| 7 | 2008 | 47 | |
| 8 | 2014 | 29 | |
| 9 | 2011 | 26 | |
| 10 | 2007 | 23 | |
| 11 | Phase I/II trial of the novel Hsp90 inhibitor, IPI-504, in patients with relapsed and/or refractory stage IIIB or stage IV non-small cell lung cancer stratified by EGFR mutation status | 2007 | 14 |
| 12 | 2006 | 13 | |
| 13 | 2009 | 11 | |
| 14 | 2014 | 7 | |
| 15 | 2006 | 7 | |
| 16 | 2010 | 7 | |
| 17 | 2004 | 6 | |
| 18 | 2009 | 6 | |
| 19 | 2005 | 4 | |
| 20 | 2007 | 3 |
About David Grayzel
David Grayzel is a scholar working on Molecular Biology, Oncology, Computational Theory and Mathematics, Pulmonary and Respiratory Medicine and Psychiatry and Mental health, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Heat shock proteins research (9 papers), Computational Drug Discovery Methods (5 papers), Migraine and Headache Studies (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Treatment and Pharmacology (2 papers), T-cell and Retrovirus Studies (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Psychiatry and Mental health (370 citations), Pathology and Forensic Medicine (197 citations), Gastroenterology (57 citations), Hematology (98 citations) and Pulmonary and Respiratory Medicine (215 citations). David Grayzel has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Steven Sweeney, Peter J. Goadsby, Egilius L.H. Spierings, David W. Dodick, John R. Walker, Lecia V. Sequist, Pasi A. Jänne, Scott Gettinger, Ronald B. Natale and Jennifer Sweeney. Their work appears in journals such as Journal of Clinical Oncology, Blood, Frontiers in Pharmacology, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.